These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

75 related articles for article (PubMed ID: 29235880)

  • 21. A randomized, double-blind, placebo-controlled study comparing the efficacy and safety of ebastine (20 mg and 10 mg) to loratadine 10 mg once daily in the treatment of seasonal allergic rhinitis.
    Hampel F; Howland W; Van Bavel J; Ratner P
    J Investig Allergol Clin Immunol; 2004; 14(1):56-63. PubMed ID: 15160443
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Acquired cold urticaria symptoms can be safely prevented by ebastine.
    Magerl M; Schmolke J; Siebenhaar F; Zuberbier T; Metz M; Maurer M
    Allergy; 2007 Dec; 62(12):1465-8. PubMed ID: 17900265
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Efficacy of ebastine, cetirizine, and loratadine in histamine cutaneous challenges.
    Gispert J; Antonijoan R; Barbanoj M; Gich I; Garcia E; Esbrí R; Luria X
    Ann Allergy Asthma Immunol; 2002 Sep; 89(3):259-64. PubMed ID: 12269645
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Prevention of signs and symptoms of dermographic urticaria by single-dose ebastine 20 mg.
    Magerl M; Schmolke J; Metz M; Zuberbier T; Siebenhaar F; Maurer M
    Clin Exp Dermatol; 2009 Jul; 34(5):e137-40. PubMed ID: 19323664
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Rupatadine 10 mg and ebastine 10 mg in seasonal allergic rhinitis: a comparison study.
    Guadaño EM; Serra-Batlles J; Meseguer J; Castillo JA; De Molina M; Valero A; Picado C;
    Allergy; 2004 Jul; 59(7):766-71. PubMed ID: 15180765
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Pharmacokinetics and safety of ebastine in healthy subjects and patients with renal impairment.
    Noveck RJ; Preston RA; Swan SK
    Clin Pharmacokinet; 2007; 46(6):525-34. PubMed ID: 17518511
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Suppression of the skin reaction to histamine by ebastine.
    Nelson HS; Bucher B; Buchmeier A; Oppenheimer J; Garcia J
    Ann Allergy Asthma Immunol; 1995 May; 74(5):442-7. PubMed ID: 7749977
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Blood-brain barrier transport of H1-antagonist ebastine and its metabolite carebastine.
    Tamai I; Kido Y; Yamashita J; Sai Y; Tsuji A
    J Drug Target; 2000; 8(6):383-93. PubMed ID: 11328664
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Suppression of mammalian K+ channel family by ebastine.
    Ko CM; Ducic I; Fan J; Shuba YM; Morad M
    J Pharmacol Exp Ther; 1997 Apr; 281(1):233-44. PubMed ID: 9103502
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Ebastine in the treatment of seasonal allergic rhinitis].
    Il'ina NI; Balabolkin II; Blokhin BM; Goriachkina LA; Kolganova NA; Pampura AN; Sidorenko IV
    Ter Arkh; 1998; 70(9):79-81. PubMed ID: 9821236
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Treatment of mosquito bites with ebastine: a field trial.
    Karppinen A; Petman L; Jekunen A; Kautiainen H; Vaalasti A; Reunala T
    Acta Derm Venereol; 2000; 80(2):114-6. PubMed ID: 10877131
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Investigation of the efficacy and tolerability of azelastine nasal spray versus ebastine tablets in patients with seasonal allergic rhinitis].
    Antépara I; Jaúregui I; Basomba A; Cadahia A; Feo F; García JJ; Gonzalo MA; Luna I; Rubio M; Vázquez M
    Allergol Immunopathol (Madr); 1998; 26(1):9-16. PubMed ID: 9585822
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Ebastine increases IFN-gamma production in patients with persistent allergic rhinitis.
    Ciprandi G; Cirillo I; Pistorio A; Di Gioacchino M; Fenoglio D
    J Biol Regul Homeost Agents; 2009; 23(1):31-6. PubMed ID: 19321044
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Parametrization by nonlinear regression analysis of the active acid metabolite of ebastine using different weighting methods.
    Mariño EL; Jansat JM; March MA; Lastra CF
    Int J Clin Pharmacol Ther; 1996 Dec; 34(12):546-9. PubMed ID: 8996850
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Pharmacokinetics and safety of ebastine in patients with impaired hepatic function compared with healthy volunteers: a phase I open-label study.
    Lasseter KC; Dilzer SC; Vargas R; Waldman S; Noveck RJ
    Clin Pharmacokinet; 2004; 43(2):121-9. PubMed ID: 14748620
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Ebastine improves nasal symptoms and airflow and affects response to decongestion test in patients with persistent allergic rhinitis: a pilot study.
    Ciprandi G; Cirillo I; Mora F; La Rosa M
    Allergy Asthma Proc; 2007; 28(5):578-81. PubMed ID: 17883885
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Multicenter study of satisfaction with fast-dissolving ebastine, 20 mg/ day, in Mexican patients with allergic rhinitis].
    Aguilar D; Arias A; Báez C; González S; Hernández D; Linares FJ; López A; Macías A; Martínez A; Martínez HM; Martínez N; Mogica MD; Paz D; Rojo I; Sánchez A
    Rev Alerg Mex; 2009; 56(2):36-40. PubMed ID: 19526952
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Pharmacokinetics of the H1-receptor antagonist ebastine and its active metabolite carebastine in healthy subjects.
    Yamaguchi T; Hashizume T; Matsuda M; Sakashita M; Fujii T; Sekine Y; Nakashima M; Uematsu T
    Arzneimittelforschung; 1994 Jan; 44(1):59-64. PubMed ID: 7907873
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [New generation antihistamines as monotherapy or in combination. What is the relevance for daily clinical routine for allergic rhinoconjunctivitis].
    Mösges R; Köberlein J
    HNO; 2007 Jun; 55(6):457-64. PubMed ID: 17566806
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The effects of single and repeated administration of ebastine on cognition and psychomotor performance in comparison to triprolidine and placebo in healthy volunteers.
    Hindmarch ; Shamsi Z
    Curr Med Res Opin; 2001; 17(4):273-81. PubMed ID: 11922401
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.